REDMILE GROUP, LLC – Verve Therapeutics, Inc. Transaction History
REDMILE GROUP, LLC portfolio value:
$51.70M
portfolio value
REDMILE GROUP, LLC quarter portfolio value change:
+124.80%
quarter
Verve Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -17.91% | -328.42K shares | 23.68M | $34.35 | 1.50M |
| Q2 2022 | share | Decrease | -0.10% | -1.78K shares | -13.86M | $15.28 | 1.83M |
| Q1 2022 | share | Increase | +7.42% | 126.79K shares | -21.11M | $22.82 | 1.83M |
| Q4 2021 | share | Decrease | -8.59% | -160.49K shares | -24.85M | $37.72 | 1.70M |
| Q3 2021 | share | Decrease | -3.49% | -67.5K shares | -28.83M | $47 | 1.86M |
| Q2 2021 | share | Increase | 0.00% | 1.93M shares | 116.67M | $60.25 | 1.93M |